193 related articles for article (PubMed ID: 11575444)
21. The role of postprandial releases of insulin and incretin hormones in meal-induced satiety--effect of obesity and weight reduction.
Verdich C; Toubro S; Buemann B; Lysgård Madsen J; Juul Holst J; Astrup A
Int J Obes Relat Metab Disord; 2001 Aug; 25(8):1206-14. PubMed ID: 11477506
[TBL] [Abstract][Full Text] [Related]
22. The entero-insular axis in type 2 diabetes--incretins as therapeutic agents.
Creutzfeldt W
Exp Clin Endocrinol Diabetes; 2001; 109 Suppl 2():S288-303. PubMed ID: 11460578
[TBL] [Abstract][Full Text] [Related]
23. Glucagon-like peptide-1 is a physiological incretin in rat.
Wang Z; Wang RM; Owji AA; Smith DM; Ghatei MA; Bloom SR
J Clin Invest; 1995 Jan; 95(1):417-21. PubMed ID: 7814643
[TBL] [Abstract][Full Text] [Related]
24. Endogenous GLP-1 regulates postprandial glycemia in humans: relative contributions of insulin, glucagon, and gastric emptying.
Nicolaus M; Brödl J; Linke R; Woerle HJ; Göke B; Schirra J
J Clin Endocrinol Metab; 2011 Jan; 96(1):229-36. PubMed ID: 21047924
[TBL] [Abstract][Full Text] [Related]
25. Glucagon-like peptide I enhances the insulinotropic effect of glibenclamide in NIDDM patients and in the perfused rat pancreas.
Gutniak MK; Juntti-Berggren L; Hellström PM; Guenifi A; Holst JJ; Efendic S
Diabetes Care; 1996 Aug; 19(8):857-63. PubMed ID: 8842604
[TBL] [Abstract][Full Text] [Related]
26. [Studies on the relation between late dumping syndrome and glucagon responses to glucose].
Matsui T
Nihon Heikatsukin Gakkai Zasshi; 1988 Jun; 24(3):159-70. PubMed ID: 3073247
[TBL] [Abstract][Full Text] [Related]
27. Normalization of glucose concentrations and deceleration of gastric emptying after solid meals during intravenous glucagon-like peptide 1 in patients with type 2 diabetes.
Meier JJ; Gallwitz B; Salmen S; Goetze O; Holst JJ; Schmidt WE; Nauck MA
J Clin Endocrinol Metab; 2003 Jun; 88(6):2719-25. PubMed ID: 12788879
[TBL] [Abstract][Full Text] [Related]
28. Glucagon-like peptide-1 and control of insulin secretion.
Thorens B
Diabete Metab; 1995 Dec; 21(5):311-8. PubMed ID: 8586147
[TBL] [Abstract][Full Text] [Related]
29. Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients.
Herrmann C; Göke R; Richter G; Fehmann HC; Arnold R; Göke B
Digestion; 1995; 56(2):117-26. PubMed ID: 7750665
[TBL] [Abstract][Full Text] [Related]
30. Acarbose improves hypoglycaemia following gastric bypass surgery without increasing glucagon-like peptide 1 levels.
Valderas JP; Ahuad J; Rubio L; Escalona M; Pollak F; Maiz A
Obes Surg; 2012 Apr; 22(4):582-6. PubMed ID: 22161170
[TBL] [Abstract][Full Text] [Related]
31. Effects of endogenous GLP-1 and GIP on glucose tolerance after Roux-en-Y gastric bypass surgery.
Svane MS; Bojsen-Møller KN; Nielsen S; Jørgensen NB; Dirksen C; Bendtsen F; Kristiansen VB; Hartmann B; Holst JJ; Madsbad S
Am J Physiol Endocrinol Metab; 2016 Apr; 310(7):E505-14. PubMed ID: 26786780
[TBL] [Abstract][Full Text] [Related]
32. Postprandial hormone and metabolic responses in simulated shift work.
Hampton SM; Morgan LM; Lawrence N; Anastasiadou T; Norris F; Deacon S; Ribeiro D; Arendt J
J Endocrinol; 1996 Nov; 151(2):259-67. PubMed ID: 8958786
[TBL] [Abstract][Full Text] [Related]
33. Is glucagon-like peptide 1 an incretin hormone?
Nauck MA
Diabetologia; 1999 Mar; 42(3):373-9. PubMed ID: 10096792
[TBL] [Abstract][Full Text] [Related]
34. Initially more rapid small intestinal glucose delivery increases plasma insulin, GIP, and GLP-1 but does not improve overall glycemia in healthy subjects.
Chaikomin R; Doran S; Jones KL; Feinle-Bisset C; O'Donovan D; Rayner CK; Horowitz M
Am J Physiol Endocrinol Metab; 2005 Sep; 289(3):E504-7. PubMed ID: 15886226
[TBL] [Abstract][Full Text] [Related]
35. Postprandial responses of incretin and pancreatic hormones in non-diabetic patients with end-stage renal disease.
Idorn T; Knop FK; Jørgensen M; Holst JJ; Hornum M; Feldt-Rasmussen B
Nephrol Dial Transplant; 2014 Jan; 29(1):119-27. PubMed ID: 24078334
[TBL] [Abstract][Full Text] [Related]
36. The enteroinsular axis and the recovery from type 2 diabetes after bariatric surgery.
Patriti A; Facchiano E; Sanna A; Gullà N; Donini A
Obes Surg; 2004; 14(6):840-8. PubMed ID: 15318993
[TBL] [Abstract][Full Text] [Related]
37. Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, regulates fasting glycemia and nonenteral glucose clearance in mice.
Baggio L; Kieffer TJ; Drucker DJ
Endocrinology; 2000 Oct; 141(10):3703-9. PubMed ID: 11014225
[TBL] [Abstract][Full Text] [Related]
38. Effects of glucagon-like peptide 1 on counterregulatory hormone responses, cognitive functions, and insulin secretion during hyperinsulinemic, stepped hypoglycemic clamp experiments in healthy volunteers.
Nauck MA; Heimesaat MM; Behle K; Holst JJ; Nauck MS; Ritzel R; Hüfner M; Schmiegel WH
J Clin Endocrinol Metab; 2002 Mar; 87(3):1239-46. PubMed ID: 11889194
[TBL] [Abstract][Full Text] [Related]
39. [Impaired glucose tolerance in dumping syndrome].
Itoh H
Nihon Rinsho; 2005 Feb; 63 Suppl 2():295-9. PubMed ID: 15779391
[No Abstract] [Full Text] [Related]
40. Influence of glucagon-like peptide 1 on fasting glycemia in type 2 diabetic patients treated with insulin after sulfonylurea secondary failure.
Nauck MA; Sauerwald A; Ritzel R; Holst JJ; Schmiegel W
Diabetes Care; 1998 Nov; 21(11):1925-31. PubMed ID: 9802745
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
